Harvard and German firm Evotec collaborate in motor neuron disease
This article was originally published in Scrip
Executive Summary
Evotec of Germany has entered a collaboration with Harvard Stem Cell Institute to identify compounds that prevent or slow down the loss of motor neurons, a characteristic of amyotrophic lateral sclerosis (ALS).